7 TIMES SQUARE, NEW YORK, NY
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Reports Full Year 2025 Financial Results and Provides Corporate Update
SELLAS Life Sciences Secures $42.6 Million from Warrant Exercises
SELLAS Life Sciences Reports $71.8M Cash Position and $26.5M from Warrants
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
News, Material Contracts
Q1
FY 2025
Q3
Q2
FY 2024
S-3ASR
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload